Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies

BACKGROUND: Previous reports showed that CYP2E1 RsaI/PstI polymorphism may be a risk factor for cancers. Published meta-analyses in 2010 and 2011, respectively, on the relationship of CYP2E1 RsaI/PstI polymorphisms with the susceptibility to head and neck carcinoma (HNC) have generated inconsistent...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Xianlu, Song, Jue, Liao, Jian, Zhou, Wei, Ye, Huiping, Li, Qi, Xiang, Zhaolan, Zhang, Xueyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089101/
https://www.ncbi.nlm.nih.gov/pubmed/27787372
http://dx.doi.org/10.1097/MD.0000000000005156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089101/
https://www.ncbi.nlm.nih.gov/pubmed/27787372
http://dx.doi.org/10.1097/MD.0000000000005156

Ejemplares similares